ILMN · Illumina, Inc.

$190.89 -1.75 (-0.91%) At close · Aug 14

Market Cap

$28.82B

151.00M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-07-16	Illumina expands Billion Cell Atlas program with new AI drug developers
2026-07-09	Illumina to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026
2026-07-09	Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
2026-06-23	Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
2026-06-08	Illumina launches StrataMap Spatial Solution, a powerful end-to-end spatial whole transcriptome research solution
2026-05-28	Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
2026-05-28	Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
2026-05-21	David P. King elected to Illumina's Board of Directors
2026-05-19	Illumina releases 2025 Corporate Responsibility Report, expanding access to genomics and accelerating global impact
2026-04-30	Illumina Reports Financial Results for First Quarter of Fiscal Year 2026
2026-04-16	DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
2026-04-14	Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
2026-04-09	Illumina to Announce First Quarter 2026 Financial Results on Thursday, April 30, 2026
2026-04-02	Illumina Announces Changes to Board of Directors

Past events

Date	Event	Type
2026-07-30	Q2 2026 Illumina, Inc. Earnings Conference Call	Earnings call
2026-04-30	Q1 2026 Illumina, Inc. Earnings Conference Call	Earnings call
2026-03-03	TD Cowen 46th Annual Health Care Conference	Conference
2026-02-05	Q4 and Fiscal Year 2025 Illumina, Inc. Earnings Conference Call	Earnings call
2026-01-13	44th Annual J.P. Morgan Healthcare Conference	Conference
2025-11-19	Wolfe Research Healthcare Conference 2025	Conference
2025-10-30	Q3 2025 Illumina, Inc. Earnings Conference Call	Earnings call
2025-10-08	Illumina Stewardship-Focused Update (October 2025)	Event
2025-07-31	Q2 2025 Illumina, Inc. Earnings Conference Call	Earnings call
2025-06-23	Illumina to Acquire Somalogic	Event
2025-05-28	41st Annual Bernstein Strategic Decisions Conference	Conference
2025-05-08	Q1 2025 Illumina, Inc. Earnings Conference Call	Earnings call
2025-02-25	Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference	Conference
2025-02-06	Q4 and Fiscal Year 2024 Illumina, Inc. Earnings Conference Call	Earnings call
2025-01-14	43rd Annual J.P. Morgan Healthcare Conference	Conference
2024-12-03	7th Annual Evercore HealthCONx Conference	Conference
2024-11-20	Wolfe Research 2024 Healthcare Conference	Conference
2024-11-04	Q3 2024 Illumina, Inc. Earnings Conference Call	Earnings call
2024-10-22	Illumina Stewardship-Focused Update (October 2024)	Event
2024-08-13	Illumina Strategy Update	Event
2024-08-06	Q2 2024 Illumina, Inc. Earnings Conference Call	Earnings call
2024-06-24	GRAIL Spin-off	Event
2024-05-29	Bernstein 40th Annual Strategic Decisions Conference	Conference
2024-05-14	RBC 2024 Global Healthcare Conference	Conference
2024-05-13	GRAIL Capital Markets Day 2024	Event

Source: https://investor.illumina.com/

Key facts CIK 1110803 CUSIP 452327109 13F (30d) 856 filings 826 filers Visit website Investor relations